A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion

Cancer Detection and Prevention

Volumn 29, Issue 4, 2005, Pages 323-331

  Man, Yan Gao ^a   Shen, Ting ^b   Weisz, Judith ^c   Berg, Patricia E ^d   Schwartz, Arnold M ^d   Mulshine, James L ^e   Sang, Qing Xiang Amy ^f   Nieburgs, Herbert E ^g  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f FLORIDA STATE UNIVERSITY   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Anti mitotic agents; Breast tumor cells; Ductal carcinoma in situ; Estrogen receptor; Morphologic features; Myoepithelial cells; Progression related markers; Stem cells; Stromal and vascular invasion; Tumor invasion and metastasis; Vascular invasion

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN;

ARTICLE; BREAST TUMOR; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STROMA CELL; TUMOR CELL;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL PROLIFERATION; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; RECEPTORS, ESTROGEN; STROMAL CELLS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 24644463323     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.06.010     Document Type: Article

References (55)

1. A. Tsubura, N. Shikata, and T. Inui Immunohistochemical localization of myoepithelial cells and basement membrane in normal, benign and malignant human breast lesions Virchows Arch 413 1988 133 139
2. F. Jolicoeur, T.A. Seemayer, and G. Gabbiani Multifocal, nascent, and invasive myoepithelial carcinoma (malignant myoepithelioma) of the breast: an immunohistochemical and ultrastructural study Int J Surg Pathol 10 2002 281 291
3. A. Nerlich Morphology of basement membrane and associated matrix proteins in normal and pathological tissues Veroff Pathol 145 1995 1 139
4. R.H. Goldfarb, and L.A. Liotta Proteolytic enzymes in cancer invasion and metastasis Semin Thromb Hemost 12 1986 294 307
5. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer: trial and tribulations Science 295 5564 2002 2387 2392
6. L.M. Matrisian, G.W. Sledge Jr., and S. Mohla Exacellular proteolysis and cancer: meeting summary and future directions Cancer Res 63 2003 6105 6109
7. Y.G. Man, L. Tai, and R. Barner Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion Breast Cancer Res 5 2003 R231 R241
8. Y.G. Man, and Q.X.A. Sang The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis Exp Cell Res 301 2004 103 118
9. M. Yousefi, R. Mattu, C. Gao, and Y.G. Man Mammary ducts with and without focal myoepithelial cell layer disruptions show a different frequency of white blood cell infiltration and growth pattern: implications for tumor progression and invasion AIMM 13 2005 30 37
10. Y.G. Man, Y. Zhang, and T. Shen cDNA expression profiling identifies elevated expressions of tumor progression and invasion related genes in cell clusters of in situ breast tumors Breast Cancer Res Treat 89 2005 199 208
11. Y.G. Man, K.M. Shekitka, and G.L. Bratthauer Immunohistochemical and genetic alterations in mammary epithelial cells overlying focally disrupted myoepithelial cell layers Breast Cancer Res Treat 76 Suppl 1 2002 S143, S569
12. Y.G. Man, R. Zhang, and R. Mattu A subset of mammary epithelial cells overlying focally disrupted myoepithelial cell layers shows an unusual immunostaining pattern for proliferation-related proteins Breast Cancer Res Treat 82 Suppl 1 2003 S163 S164
13. Y.G. Man, J.S. Saenger, and R.S. Vang Identification of invasive precursor cells in normal and hyperplastic breast tissue Proceedings of the American Association for Cancer Research Cancer Res 44 2003 68, 357
14. Y.G. Man, R. Mattu, and R. Zhang A subset of normal and hyperplastic appearing mammary ductal cells display invasive features Breast Cancer Res Treat 82 Suppl 1 2003 141
15. Y.G. Man, P.E. Berg, and R. Barner Morphologically similar normal and hyperplastic mammary ductal cells associated with and without malignant lesions have a different immunohistochemical profile Cancer Detect Prev 2004 282 [Symposium Issue S-137]
16. R. Clarke, N. Brunner, and B.S. Katzenellenbogen Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo Proc Natl Acad Sci USA 86 1989 3649 3653
17. M.S. Sheikh, M. Garcia, and P. Pujol Why are estrogen receptor negative breast cancers more aggressive than the estrogen receptor positivebreast cancers? Invasion Metastasis 14 1994-1995 329 336
18. M.S. Frech, E.D. Halama, and M.T. Tilli Degregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ Cancer Res 65 2005 681 685
19. M. AI-Hajj, and M.F. Clarke Self-renewal and solid tumor stem cells Oncogene 23 2004 7274 7282
20. G.B. Pierce, and W.C. Speers Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation Cancer Res 48 1996 1990 2004
21. F.A. Tavassoli, and Y.G. Man Morphofunctional features of intraductal hyperplasia, atypical hyperplasia, and various grades of intraductal carcinoma Breast J 1 3 1995 155 162
22. Y.G. Man, and F.A. Tavassoli A simple epitope retrieval method without the use of microwave oven or enzyme digestion Appl Immunohistochem 4 2 1996 139 141
23. Y.G. Man, and A. Burgar An antigen unmasking protocol that satisfies both immunohistochemical and subsequent molecular biological assessments Pathol Res Pract 199 2003 815 825
24. R.A. Soslow, D.L. Cardson, and M.G. Horenstein A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas Breast Cancer Res Treat 61 2000 161 170
25. M. Loden, F. Perris, and N.H. Nielsen c-erb B2, p27 and G1/S aberrations in human primary breast cancer Anticancer Res 23 2003 2053 2061
26. S. Han, K. Park, and B.N. Bae Prognostic implication of cycle E expression and its relationship with cyclin D1 and p27kip1 expression in tissue microarrays of node negative breast cancer J Surg Oncol 83 2003 241 247
27. Y.G. Zhao, A.Z. Xiao, and H.I. Park Endometase in human breast carcinoma, selective activation of progelatinase B and inhibition by tissue inhibitors of metalloproteinases-2 and -4 Cancer Res 64 2004 590 598
28. Y.G. Man, S.W. Fu, and J.J. Pinzone Expression of BP1, a homobox gene, correlates with progression and invasion of mammary ductal Carcinoma Breast Cancer Res Treat 90 2005 241 247
29. D.J. Slamon, W. Godolphin, and L.A. Jones Studies of the Her-2/new proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
30. W. Bocker Keratin 5-positive cells in the breast are progenitor cells of glandular and myoepithelial differentiation A cell biological model as a basis of breast pathology Verh Dtsch Ges Pathol 85 2001 206 207
31. P. Krishnamurthy, D.D. Ross, and T. Nakanishi The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interaction with heme J Biol Chem 279 2004 24218 24225
32. L. Hebbard, A. Steffen, and V. Zawadzki CD44 expression and regulation during mammary gland development and function J Cell Sci 113 Pt 14 2000 2619 2630
33. M. Zhang, O. Volpert, and Y.H. Shi Maspin is an angiogenesis inhibitor Nat Med 6 2000 196 199
34. M. Barbareschi, L. Pecciarini, and M.G. Cangi p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast Am J Surg Pathol 25 2001 1954 1960
35. Y.G. Man, R.S. Vang, and J.S. Saenger Co-expression of maspin and Wilms' tumor 1 proteins in mammary myoepithelial cells - implication for tumor progression and invasion Proceedings of the Department of Defense Breast Cancer Research Program Meeting, vol. 1 2002 P9, 16
36. G. Handschuh, S. Candidus, and B. Luber Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility Oncogene 8 1999 4301 4312
37. B. Luber, S. Candidus, and G. Handschuh Tumor-derived mutated E-cadherin influences beta-catenin localization and increases susceptibility to actin cytoskeletal changes induced by pervanadate Cell Adhes Commun 7 2000 391 408
38. E. Fricke, G. Keller, and I. Becker Relationship between E-cagherin gene mutation and p53 gene mutation, p53accumulation Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma Int J Cancer 104 2003 60 65
39. K. Harms, S. Nozell, and X. Chen The common and distinct target genes of the p53 family transcription factors Cell Mol Life Sci 61 2004 822 842
40. T.N. Alam, M.J. O'Hare, and I.I. Laczko Differential expression of CD44 during human prostate epithelial cell differentiation J Histochem Cytochem 52 2004 1083 1090
41. D.S. Schmidt, P. Klingbeil, and M. Schnolzer CD44 variant isoforms associate with tetraspanins and EpCAM Exp Cell Res 297 2004 329 347
42. S. Sell, and G.B. Pierce Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers Lab Invest 70 1994 6 22
43. E.C. Kordon, and G.H. Smith An entire functional mammary gland may comprise the progeny from a single cell Development 125 1998 1921 1930
44. C.C. Chang, W. Sun, and A. Cruz A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis Radiat Res 155 2001 201 207
45. G. Don'tu, M. AI-Hajj, and W.M. Abdallah Stem cells in normal breast development and breast cancer Cell Prolif 36 Suppl 1 2003 59 72
46. R.B. Clarke, E. Anderson, A. Howell, and C.S. Potten Regulation of human breast epithelial stem cells Cell Prolif 36 Suppl 1 2003 45 58
47. M.J. Hendrix, E.A. Seftor, and D.A. Kirschmann Remodeling of the microenvironment by aggressive melanoma tumor cells Ann NY Acad Sci 995 2003 151 161
48. Y.G. Man, W.D. Ball, and A.J. Culp Persistence of a perinatal cellular phenotype in the ducts of adult glands J Histochem Cytochem 43 12 1995 1203 1215
49. Y.G. Man, W.D. Ball, and L. Marchetti Contributions of intercalated duct cells to normal parenchyma of submandibular glands of adult rats Anat Rec 263 2001 202 214
50. J. Russo, and H. Russo The pathway of neoplastic transformation of human breast epithelial cells Radiat Res 155 1 Pt 2 2001 151 154
51. G. Calaf, J. Russo, and L. Tait Morphological phenotypes in neoplastic progression of human epithelial cells J Submicrosc Cytol Pathol 32 2000 83 96
52. M.R. Stampfer, A. Bodnar, and J. Garbe Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells Mol Biol Cell 8 1997 2391 2405
53. S.K. Muthuswamy, D. Li, and S. Lelievre ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini Nat Cell Biol 3 2001 785 792
54. J.F. Timms, S.L. White, and M.J. O'Hare Effects of ErbB-2 overexpression on mitogenic signaling and cell cycle progression in human breast luminal epithelial cells Oncogene 21 2002 6573 6586
55. R.B. Hazan, R. Qiao, and R. Keren Cadherin switch in tumor progression Ann NY Acad Sci 1014 2004 155 163